KIORA PHARMACEUTICALS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
KIORA PHARMACEUTICALS, INC. (KPRX) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$0.93 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-02.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2018-03-02
- KIORA PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2016-12-31 was -$1.51.
- KIORA PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2016-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2016-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2016-03-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2017 was -$0.93.
- KIORA PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2016 was -$1.51, a 100.03% decline from fiscal 2015.
- KIORA PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2015 was $5.18K, a 97.67% decline from fiscal 2014.
- KIORA PHARMACEUTICALS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2014 was $222.48K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-12-31 | -$0.93 10-K · filed 2018-03-02 | |||||
| 2016-12-31 | -$1.51 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$1.51 derived: sum of 2 quarters · filed 2018-03-02 | -$1.51 derived: sum of 3 quarters · filed 2018-03-02 | -$1.51 10-K · filed 2018-03-02 | $0.00 10-K · filed 2017-02-23 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-10 | $0.00 10-Q · filed 2016-08-10 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $5.18K 10-K · filed 2017-02-23 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $5.18K 10-Q · filed 2016-11-01 | $59.38K derived: sum of 4 quarters · filed 2016-11-01 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-10 | $5.18K 10-Q · filed 2016-08-10 | $59.38K derived: sum of 3 quarters · filed 2016-08-10 | $100.05K derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2015-03-31 | -$5.18K 10-Q · filed 2016-05-13 | $5.18K 10-Q · filed 2015-05-18 | $59.38K derived: sum of 2 quarters · filed 2016-05-13 | $100.05K derived: sum of 3 quarters · filed 2016-05-13 | $158.36K derived: sum of 4 quarters · filed 2016-05-13 | |
| 2014-12-31 | $64.56K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $105.22K derived: sum of 2 quarters · filed 2016-03-30 | $163.54K derived: sum of 3 quarters · filed 2016-03-30 | $222.48K 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $40.67K 10-Q · filed 2015-11-12 | $98.98K derived: sum of 2 quarters · filed 2015-11-12 | $157.93K 10-Q · filed 2015-11-12 | |||
| 2014-06-30 | $58.31K 10-Q · filed 2015-08-12 | $117.26K 10-Q · filed 2015-08-12 | ||||
| 2014-03-31 | $58.95K 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |